structure of tirzepatide Illustration showing the 3D structure

Less commonly used today, but still helpful in selected patients with insulin resistance and fatty liver

For people with T2D and atherosclerotic cardiovascular disease (ASCVD) or high CV risk, clinical guidelines developed by the American Diabetes Association and the European Association for the Study of Diabetes specifically recommend the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) or sodiumglucose cotransporter 2 inhibitors (SGLT2is) [9, 10], irrespective of baseline blood glucose levels or metformin use

Does PlexusDx charge more if I need a higher dose

In one trial, patients who took Wegovy lost an average of 14.9% of their body weight compared to 2.4% loss for patients on the placebo, according to Novo Nordisk

Zepbound (same active ingredient, approved for weight loss) offers self-pay vial options starting at $349 monthly through LillyDirect, which may be more affordable than Mounjaro for weight loss purposes

Sometimes things work for a while, then plateau